Cancer Treatment and Research Communications
Publisher: Elsevier · ISSN 2468-2942 · 93 articles
- Post-translational acylation of proteins in colorectal cancer
- Treatment modalities and survival outcomes among elderly patients with stage IV small-cell lung cancer and synchronous brain metastases: A retrospective seer-based cohort study
- Exploratory findings about the prognostic value of baseline circulating trimethylated H3K27 nucleosomes in treatment-intent cohorts of non-small cell lung cancer
- Redox Status and Metabolic Weaknesses of Cancer and Cancer Stem Cells for Therapeutic Efficiency for Phyto-Photodynamic Agents
- Fatty Acid-Binding Protein 4 Identifies High-Risk Patients With Colorectal Cancer and Provides Complementary Prognostic Information Beyond TNM Staging
- Lack of a systematic approach and unified standards in frailty assessment among patients with gastric cancer: a scoping review
- Multimodal AI for early lung cancer detection: from LDCT to clinical and molecular integration
- Organ-specific liquid biopsy in lung cancer: the emerging role of exhaled breath condensate
- Non-coding RNAs as mediators of tyrosine kinase inhibitor resistance in chronic myeloid leukemia: a scoping review
- Cancer-associated fibroblasts during and after therapy: disentangling state, function and persistence
- Rediscovering Kaposi Sarcoma in North Africa: Thirteen years of HIV-negative cases and survival insights from Morocco
- Rethinking cardiovascular risk stratification in TKI-treated chronic myeloid leukemia
- Hereditary cancer syndromes as a model for precision oncology: the paradigms of HRD and MSI
- Elevated expression of olfactory receptor 51T1 is associated with malignant potential of bladder cancer
- Pleural metastasis of bone and soft tissue sarcomas: A review
- Impact of primary tumor location on survival outcomes and recurrence patterns in patients with stage III non-small cell lung cancer: A retrospective observational study
- Pretreatment lactate dehydrogenase, but not magnesium or neutrophil-to-lymphocyte ratio, is independently associated with grade ≥3 chemotherapy toxicity in breast cancer: prediction-model development and internal validation in 400 patients
- Global, G20, and China burden of malignant neoplasms of bone and articular cartilage from 1990 to 2050: trends, projections, and ecological associations with healthcare expenditure
- Association of neoadjuvant radiotherapy with 10-year survival outcomes in large cell lung cancer: A retrospective SEER-based study
- Prognostic impact of residual viable tumor percentage on non-small cell lung cancer recurrence after neoadjuvant immunochemotherapy
- Diagnostic value of Node-RADS in predicting lymph node metastasis in endometrial cancer
- The prognostic value of HER2 in gastroesophageal adenocarcinoma – a meta-analysis
- Drastic muscle wasting following surgery is a strong predictor of prognosis in early-stage pancreatic cancer–a Taiwanese multicenter cohort study
- Increased abdominal visceral adipose tissue (VAT) in patients with metastatic lung adenocarcinoma under ALK inhibitors is associated with prolonged progression-free survival
- Unmet Needs, Quality of Life, and Lived Experiences of Patients with Metastatic Breast Cancer in Central Vietnam: A Convergent Mixed-Methods Study
- Prognostic implications of asymptomatic COVID-19 infection in non-small-cell lung cancer patients receiving active anticancer treatment: an observational study with prospective survival follow-up
- Immunotherapy and circulating tumor DNA in HPV-positive oropharyngeal cancer: a systematic review and exploratory meta-analysis of survival and surveillance outcomes
- Female breast and gynecological cancers in Asia, 1990–2021: Burden and trends from the global burden of disease study
- CAD potentially mediates 5‑fluorouracil resistance in gastric cancer cells via modulation of uridine monophosphate synthetase expression
- Emerging immunotherapies in melanoma beyond immune checkpoint inhibitors: Vaccines, intralesional therapies, adoptive cell therapies, and T-cell engagers